Capital Markets

• CICC as sole sponsor and 20 other underwriters in approximately US$85 million IPO of Shanghai Voicecomm Information Technology Co., Ltd. (2495.HK) on the Hong Kong Stock Exchange
• Laopu Gold (6181.HK) in its approximately US$116 million IPO and listing on the Hong Kong Stock Exchange
• CICC as the sole sponsor and overall coordinator in the approximately US$31 million IPO of Qyuns Therapeutics Co., Ltd. (2509.HK) on the Hong Kong Stock Exchange
• CICC, CCB, CMB, CMS and other underwriters in the approximately US$150 million IPO of Beijing Fourth Paradigm Technology Co., Ltd. (6682.HK) on the Hong Kong Stock Exchange
• Beijing Luzhu Biotechnology Co., Ltd. in its US$43 million IPO and listing on the Hong Kong Stock Exchange
• Beauty Farm Medical and Health Industry Inc. in its approximately US$100 million IPO and listing on the Hong Kong Stock Exchange
• 3D Medicines Inc. in its US$52 million IPO and listing on the Hong Kong Stock Exchange
• Shanghai Bio-heart Biological Technology Co., Ltd. in its US$65.3 million IPO and listing on the Hong Kong Stock Exchange
• Yonghe Medical Group Co., Ltd. in its US$206 million IPO and listing on the Hong Kong Stock Exchange
• Acotec Scientific Holdings Limited in its US$210 million IPO and listing on the Hong Kong Stock Exchange
• Goldman Sachs (Asia) L.L.C. and China International Capital Corporation Hong Kong Securities Limited and other underwriters in the US$145 million IPO and listing of Shanghai HeartCare Medical Technology Corporation Limited on the Hong Kong Stock Exchange
• J.P. Morgan, BofA Securities, CICC and Haitong International as joint sponsors and other underwriters in the approximately US$1.67 billion secondary listing of GDS Holdings Limited on the Hong Kong Stock Exchange
• Honliv Healthcare Management Group Company Limited in its US$41.3 million IPO and listing on the Hong Kong Stock Exchange
• Peijia Medical Limited in its US$343 million IPO and listing on the Hong Kong Stock Exchange
• Underwriters in the Hong Kong IPO of Legend Holdings Corporation, the controlling shareholder of Lenovo
• WuXi Biologics in its Hong Kong IPO and listing on the Main Board of the Stock Exchange of Hong Kong
• CITIC Asset Management Corporation in its reverse takeover transaction involving a new listing application of its pawn loan business on the Main Board of the Stock Exchange of Hong Kong
• 7Road Holdings Limited, a leading online game developer and operator in China, in its Hong Kong IPO and listing on the Main Board of the Stock Exchange of Hong Kong
• Digital Hollywood Interactive Limited, a leading global online game publisher, in its Hong Kong IPO and listing on the Main Board of the Stock Exchange of Hong Kong

M&A and PE Transactions

• Sequoia Capital in its investment in Ziroom, a major Chinese apartment rental service provider
• The consortium led by Yunfeng Capital and Alibaba in proposed going private transaction of iKang Healthcare Group (Nasdaq: KANG), a major provider in China's fast growing private preventive healthcare services market
• Sino IC Capital in its proposed acquisition of Xcerra Corporation (Nasdaq: XCRA), a semiconductor automatic test equipment vendor
• Tencent Holdings in its investment in Academia.edu, a US-based company that operates a platform for scientists and academics to publish and review papers online

Compliance Matters in Hong Kong IPO Transactions

• Genertec Universal Medical Group Company Limited in its major transactions, connected transactions, corporate governance, and preparation of termly reports and various disclosure document
• New China Life Insurance Co., Ltd in its connected transactions, preparation of termly reports and various corporate governance and compliance matters
• Advised Agricultural Bank of China its preparation of termly reports and various compliance matters